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Abstract 
Background: This is a case with multiple chromosomal aberrations which are likely etiological for the observed psy‑
chiatric phenotype consisting of attention deficit hyperactivity and conduct disorders.
Case presentation: We report on an 11 year‑old boy, admitted to the pediatric hospital for behavioral difficulties 
and a delayed neurodevelopmental trajectory. A cytogenetic analysis and high‑resolution microarray comparative 
genomic hybridization (CGH) analysis was performed. The cytogenetic analysis revealed 47,XYY syndrome, while CGH 
analysis revealed an additional duplication and two deletions. The 7q11.23 duplication is associated with speech and 
language delay and behavioral symptoms, a 20q13.33 deletion is associated with autism and early onset schizophre‑
nia and the 11p15.5 microdeletion is associated with developmental delay, autism, and epilepsy. The patient under‑
went a psychiatric history, physical examination, laboratory testing, and a detailed cognitive, psychiatric, and occupa‑
tional therapy evaluation which are reported here in detail.
Conclusions: In the case of psychiatric patients presenting with complex genetic aberrations and additional psycho‑
social problems, traditional psychiatric and psychological approaches can lead to significantly improved functioning. 
Genetic diagnostic testing can be highly informative in the diagnostic process and may be applied to patients in 
psychiatry in case of complex clinical presentations.
Keywords: 47,XYY syndrome, 7q11.23 Williams–Beuren syndrome region micro duplication, Conduct disorder, 
ADHD, ASD, 20q13.33 deletion syndrome, 11p15.5 deletion
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Background
With the advent of novel genetic technologies, it has 
become accessible to genetically assess patients with 
complex clinical presentations. Historically in psychia-
try, genetic assessment is not part of the standard diag-
nostic procedure. However, several recent papers have 
described a considerable diagnostic yield when looking 
for structural genetic variants (deletions, duplications, 
and larger chromosomal aberrations) [1, 2].
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47,XYY syndrome is such a chromosomal abnormal-
ity known to occur in 1 out of 1000 male births [3]. The 
etiology of the additional Y chromosome is a paternal 
nondisjunction at meiosis II. In some cases, the failure 
occurs in the cell division of the postzygotic mitosis in 
early embryonic development and produces a mosaic 
46,XY/47,XYY karyotype. The chromosomal aberration 
was first discovered and diagnosed by Sandberg and 
colleagues in the US [4] and is also originally known as 
Jacob’s syndrome [5]. 47,XYY syndrome is difficult to 
diagnose since there is no hallmark phenotype by which 
the syndrome can be recognized; the only phenotype 
often associated with the 47,XYY karyotype is that of 
tall stature. Furthermore, given that paternal nondis-
junction lies at the basis of the etiology of the genotype, 
47,XYY syndrome is not known to be hereditary, but 
instead occurs de novo.
Although 47,XYY syndrome was first described in 
1961, an increased risk for neurodevelopmental disorders 
has been documented only recently [6]. A child with this 
abnormality may develop mild learning disability, delayed 
speech and language development, reading difficulties 
needing remedial help [7, 8] and motor difficulties [9]. 
Families frequently report behavioral problems such as 
temper tantrums, impulsiveness and aggressive or vio-
lent behavior. Furthermore, they report their sons are not 
empathetic and that they lack social skills [3, 10]. These 
boys are described as restless, hyperactive, or inattentive 
while the rates of anxiety and depression are above those 
for the general population [9, 11]. An association has 
been found between the 47,XYY genotype and autism 
spectrum disorders (ASD) [3, 10, 12]. In a cross-sectional 
descriptive study of males with 47,XYY syndrome, there 
was found an increased incidence of asthma, seizures, 
tremor, and ASD compared to the general population 
rates. Prenatally diagnosed boys scored significantly bet-
ter on cognitive testing and were less likely to be diag-
nosed with ASD [13].
Duplications of 7q11.23, the locus corresponding to 
the deletion in Williams–Beuren Syndrome (WBS), have 
been implicated in ASD [14–18]. The common denomi-
nator in patients with the 7q11.23 duplication appears to 
be the neurodevelopmental delay, speech delay, separa-
tion anxiety disorders, and obsessive–compulsive behav-
ior experienced in childhood and early adolescence.
The aim of the present case report is three-fold: (1) to 
bring under the attention that genetic syndromes may 
underlie psychiatric disorders, (2) to present this case 
with multiple chromosomal aberrations which are prob-
ably etiological for the observed psychiatric phenotype 
consisting of ADHD and conduct disorder, and (3) to pre-
sent how we clinically managed symptoms and achieved 
improvement of the behavioral symptoms.
Case presentation
An 11-year-old boy was referred to the inpatient unit 
of the University Department of Child Psychiatry, 
at the “Aghia Sophia” Children’s Hospital, Athens, 
Greece, for further diagnostic evaluation and treat-
ment by the pediatric liaison team on call. He was 
socially isolated at school and in the rural community 
where he lived. He had behavioral difficulties at home 
and difficulties in adhering to the boundaries set by the 
parents. His mother labeled him as a ‘troublemaker’ 
and he was oppositional at school with inappropriate 
behavior. He was frequently interfering with teach-
ing in the classroom. Although he wanted to social-
ize with other children, he was clumsy and aggressive 
in his attempts to initiate contact. Teachers and other 
children’s’ parent’s complaints objectified the presence 
of behavioral problems. His behavior was described as 
aggressive and violent. He had odd interests. His play 
and his reactions were often inappropriate and fear 
provoking to others, i.e. he performed animal amputa-
tions, made and collected poisons, destroyed objects, 
and set fires.
Early development and family history
The patient was born at full term from non-consan-
guineous parents with a birth weight of 3750 g. He was 
treated with phototherapy for jaundice and had no fur-
ther neonatal complications. He was not breast fed, was a 
quiet baby and in the first 3 months of his life his mother 
became worried as he was unresponsive to cuddles and 
hugs. He also never cried. He uttered his first words at 
12 months of age, he spoke his first sentence at 2, 5 years 
of age and at 3, 5 years of age he was fully conversational. 
The patient’s first three years of life were spent under 
maternal care until he attended day-care starting at the 
age of 3.5  years. There, he presented with separation 
anxiety. Also, he did not spontaneously approach other 
children, he was very active and he would only take part 
in activities that interested him. Currently, he attends pri-
mary school. He is more sociable, but still he approaches 
his schoolmates on his own terms. He has severe learn-
ing disabilities (especially in reading and writing) and 
requires extra teaching help. He has no friends and, on 
occasions, he has been victimized by bullying at school 
and in the community. He suffers from primary noc-
turnal enuresis and occasional fecal soiling by day. The 
patient has two female siblings, an 18 year-old one, cur-
rently a university student and recently diagnosed with 
bipolar disorder, and a 10 year-old one, currently in pri-
mary school. His father is 44 years of age and describes 
having had a difficult childhood; he is characterized by 
the family as indifferent to the children’s problems and 
verbally violent towards his wife and son, but less so to 
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his daughters. The mother is 41 years old, and describes 
herself as having a close relationship with her children 
and mentioned that she usually covers up for the patient’s 
difficulties and makes excuses for his violent outbursts. 
The maternal grandmother suffers from depression and 
has a history of attempted suicide. She is currently using 
antidepressant medication. There are also thyroid prob-
lems in the two female siblings, the mother and her two 
sisters; heart problems in four of mother’s siblings and 
the maternal grandmother; cervical/ovarian cancer in 
the paternal grandmother; and lung cancer of paternal 
grandfather. One of the maternal sisters has a history of 
cervical cancer, heart problems, diabetes mellitus, and 
psychiatric problems (probably depression; she is cur-
rently using medication). Some of the patient’s relatives 
are also obese or overweight: his mother, his younger sis-
ter, maternal grandmother and two of maternal sisters.
Physical/psychiatric/psychological/occupational therapy 
examination
The patient was an overweight pre-adolescent of tall 
stature (height: 167  cm, weight: 73  kg*, BMI: 26.25), as 
are his older sister, mother, and maternal grandpar-
ents. There are no apparent dysmorphias present in the 
patient, nor in his siblings and parents. He was likeable 
with elements of oddness during the clinical contact, as 
well as in the way he walked and moved in the clinic. His 
medical history includes coloboma of the iris with almost 
total vision loss of the left eye and myopia and astigma-
tism of the right eye. He was interviewed by using the 
semi-structured psychiatric interview K-SADS-PL, and 
received the diagnosis of both Conduct and Attention 
Deficit Hyperactivity Disorders. On Children’s Global 
Assessment Scale (CGAS), he scored 41–50 (moderate 
effect on functionality). On the Child Behavior Checklist 
(CBCL), he scored in the clinical range on externalizing 
(oppositionality, aggression, rule violation, and conduct 
problems), internalizing (anxiety, depression), and social 
and attention problems. On the Youth Self-Report (YSR), 
he scored in the clinical range, as he did on the CBCL. On 
the ADHD Rating Scale-5 for children and adolescents, 
the ratings of both parents and teachers were indicative 
of a combined type ADHD symptoms (inattention and 
hyperactivity/impulsiveness). The Autism Diagnostic 
Interview-Revised (ADI-R) was also performed and he 
scored above the cut-off on restricted, repetitive and ste-
reotype behaviors and interests. In all other ADI-R sub-
scales, the ratings were below the cut-offs for ASD. The 
psychiatric diagnosis, according to DSM-IV-TR [19] was 
conduct disorder (childhood onset, 312.81) and ADHD 
(combined type, 314.01). On axis IV, there were problems 
with the primary care taking group (lack of support by 
family, family quarrels), academic problems/difficulties, 
and conflicts with peers and teachers. The routine labo-
ratory chemistry tests and the structural brain-MRI were 
normal.
His overall IQ score, as measured by WISC-III-R, was 
75, but his profile was considered discordant: his per-
formance IQ was 22 units superior to his verbal IQ, with 
heterogeneous performance. He had severe difficulties in 
abstract thinking, verbal conceptualization, and execu-
tive functioning while he scored better in visual construct 
and visual spatial reasoning. The projective tests (H.T.P., 
C.A.T.) depicted limited emotional intelligence, difficulty 
in processing things that bothered him, loneliness and 
rage which he was trying to repress. He needs relation-
ships but doesn’t know how to associate with people and 
has many projections around aggression and loss.
On the Behavior Observation Guide (BOSS), he had 
deficits in communication, management of money, edu-
cational activities, play, social participation and motor 
activities (bilateral body coordination, balance, static 
control and fine activity). On the Occupational Therapy 
Practice Framework Domain and Process, he demon-
strated difficulties in sustaining attention, organizing 
tasks, remaining seated, and impulsive behaviors; his 
main difficulty was in visual motor coordination and 
skills. As a result, on the ABC-2-Movement Assessment 
Battery for children-2, he scored on the 9th percentile. 
On the Developmental Test of Visual Perception-2, he 
performed in most scales below average to normal with 
the exception of visual motor completion with scores 
showing significant pathology. The difficulties described 
above may well have contributed to his reading and 
writing difficulties. On the Vineland Adaptive Behav-
ior Scales, he performed poor on written and verbal, as 
well as on community and domestic everyday activities. 
In general, he presents with mild difficulties in adaptive 
behavior and moderate maladaptive behaviors.
Patient’s progress report
During his stay (for 2½ months) in the inpatient unit, the 
patient underwent psychiatric and pediatric assessments 
plus occupational therapy. He took part in the unit’s 
psycho-educational activities and was started on risperi-
done, 2 mg daily. Risperidone was preferred over an anti-
ADHD agent because his behavioral problems prevailed 
and thus were the main target of treatment. In addition, 
his behavioral problems had undoubtedly influenced his 
functionality and mainly his relations with parents, sib-
lings, peers, teachers and others. Risperidone was also 
preferred over other atypical antipsychotics for its safe 
profile and fewer side effects. Family meetings were held 
regularly, and parental and family support along with 
psycho-education were the main goals. He was aided in 
recognizing his own emotions and conveying them to 
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others as well as in learning how to recognize the emo-
tions of others and to become aware of the consequences 
of his actions. Improvement was made in rule setting and 
boundary adherence. Since his discharge, he received 
regular psychiatric follow up, continues with the medi-
cation and the occupational therapy. Supportive and 
advisory work is done with the parents. Marked improve-
ment in general has been noticed regarding his social 
behavior and behavior during activity as described by all 
concerned. Occasional anger outbursts of smaller inten-
sity and frequency have been reported, but seem more 
manageable by the child with the support of his mother 
and teachers.
Genetic methods
Isolation of genomic DNA
Genomic DNA was extracted from peripheral blood 
lymphocytes using standard procedures. The quality and 
quantity of the DNA samples were determined using the 
NanoDrop ND-1000 UV–Vis spectrophotometer.
Cytogenetic analysis
Chromosomal analyses of the patient were performed 
from peripheral blood samples by conventional G-band-
ing techniques according to the standard protocol. Fifty 
metaphases, with 550-band resolution (>5  Mb), were 
analyzed.
Array comparative genomic hybridization (aCGH)
High resolution aCGH analysis was performed on the 
DNA sample from the patient. Agilent Human Genome 
4X180 K CGH + SNP microarrays with an average spatial 
resolution of 12 kb was used in the study (Agilent Tech-
nologies, Santa Clara, CA). The methodology used for 
aCGH and analysis of the resulting data was as previously 
described [20, 21], with the exception of the latest version 
of CytoGenomics 3.0 software (Agilent Technologies, 
Santa Clara, CA) being used for both feature extraction 
and data analysis. For the location of genes in the deleted 
or duplicated genomic segments the UCSC (http://
genome.ucsc.edu/) and the Database of Genomic Vari-
ants (http://projects.tcag.ca/variation/; human genome 
build 19) were used.
Informed consent for genetic testing was obtained 
from the parents.
Genetic results
Conventional G-banding karyotyping revealed 47,XYY 
karyotype. aCGH testing revealed three additional chro-
mosomal micro-aberrations: an 882.9 Kb duplication on 
the long arm of chromosome 7 (7q11.23), a 1.6 Mb dele-
tion on the short arm of chromosome 11 (11p15.5), and 
a 907.3 Kb deletion on the long arm of chromosome 20 
(20q13.33) (Table 1, Fig. 1a–c).
Conclusions
47,XYY syndrome is associated with various conditions 
including conduct problems and ADHD, a finding that 
applies in the case presented here. Childhood ADHD is 
strongly associated with a significantly increased risk of 
comorbid conduct disorder, personality disorder, and 
substance-related disorders. There is an association 
between ADHD and the likelihood of having an internal-
izing or externalizing disorder [22]. Association between 
sociodemographic factors, high social deprivation, pov-
erty and increased risk of externalizing and internalizing 
disorders is also observed and the strongest association 
is that between moderately deprived neighborhoods and 
ADHD [23].
In the case of this boy, apart from the additional Y 
chromosome, three additional copy number variants 
(CNVs) were detected by aCGH. The duplication at 
7q11.23 is reciprocal to the deletion associated with Wil-
liams–Beuren syndrome. Both deletions and duplications 
Table 1 Additional micro-aberrations of the 47,XYY proband
(UCSC Genome Browser, human genome build 19)
Nomenclature according to ISCN Size Important genes
7q11.23 (74,144,422‑75,027,348)x3 882.9 Kb GTF2I, NCF1, GTF2IRD2, STAG3L2, PMS2P5, GATSL1, WBSCR16, GTF2IRD2B, NCF1C, LOC100093631, 
GTF2IP1, GATSL2, SPDYE8P, PMS2L2, STAG3L1, TRIM74, TRIM73
11p15.5 (383,89‑2014,937)x1 1.6 Mb PKP3, SIGIRR, ANO9, PTDSS2, RNH1, HRAS, LRRC56, C11orf35, RASSF7, MIR210, LOC143666, PHRF1, IRF7, 
CDHR5, SCT, DRD4, DEAF1, TMEM80, EPS8L2, TALDO1, PDDC1, CEND1, SLC25A22, LRDD, RPLP2, 
SNORA52, PNPLA2, EFCAB4A, CD151, POLR2L, TSPAN4, CHID1, AP2A2, MUC6, MUC2, MUC5B, TOLLIP, 
LOC255512, BRSK2, MOB2, DUSP8, LOC338651, KRTAP5‑1, KRTAP5‑2, KRTAP5‑3, KRTAP5‑4, KRTAP5‑
5, FAM99A, FAM99B, KRTAP5‑6, LOC402778, CTSD, SYT8, TNNI2, LSP1, MIR4298, TNNT3, MRPL23, 
LOC100133545
20q13.33 (61,632,196‑62,539,530)x1 907.3 Kb BHLHE23, LOC63930, NCRNA00029, LOC100144597, HAR1B, HAR1A, MIR124‑3, YTHDF1, BIRC7, 
MIR3196, NKAIN4, FLJ16779, ARFGAP1, MIR4326, COL20A1, CHRNA4, KCNQ2, EEF1A2, PPDPF, PTK6, 
SRMS, C20orf195, PRIC285, GMEB2, STMN3, RTEL1, RTEL1‑TNFRSF6B, TNFRSF6B, ARFRP1, ZGPAT, LIME1, 
SLC2A4RG, ZBTB46, ABHD16B, TPD52L2, DNAJC5
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at this locus are associated with behavioral problems 
(anxiety disorders, ADHD, ASD), facial dysmorphisms, 
developmental coordination disorders, speech sound dis-
orders and medical problems, and MRI structural abnor-
malities [14, 18]. The 11p15.5 microdeletion contains 
amongst others the DRD4 gene responsible for regulat-
ing many neurological functions related to psychiatric 
disorders, developmental delays, as well as to neuroleptic 
response [24]. However, the molecular-pharmacological 
effect of the loss of one entire copy of the gene in this 
specific and other polymorphisms remains to be elu-
cidated. The deletion at 20q13.33 contains three genes 
(HAR1A, CHRNA4, and KCNQ2) known to be associated 
with clinical phenotypes. The HAR1A gene is considered 
an accelerated evolution gene for human brain develop-
ment with molecular defects of the gene leading to psy-
chotic and disruptive disorders [25]; the genes CHRNA4 
and KCNQ2 also deleted have been associated with ASD 
and epilepsy [26, 27].
The 47,XYY syndrome has traditionally been associ-
ated with increased behavioral problems and to criminal 
behavior. We also know that 47,XYY is associated with 
ADHD and ASD symptoms, developmental delays and 
learning disabilities [3, 7, 10, 28]. It is well known that 
Fig. 1 Array comparative genomic hybridization (Agilent 4X180 K) a image of the 7q11.23 (882.9 kb) duplicated region, b image of the 11p15.5 
(1.6 Mb) deletion, c 20q13.33 (907.3 Kb) deletion, showing the genes in the specific chromosomal regions (http://genome.ucsc.edu/; GRCh37/hg19)
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boys with co-occurring ADHD and conduct problems are 
identified as being at high risk of lifelong trajectories of 
delinquent behavior and antisocial personality [29], and 
excess mortality mainly driven by deaths from unnatu-
ral causes, especially accidents [30]. Margari et  al. [31] 
found that juvenile offenders who had committed crimes 
against people showed more ADHD symptoms and con-
duct problems than adolescents who had committed 
property crimes and alcohol-drug-related crimes.
Nevertheless, the relevant studies have different meth-
odological limitations [32]. A recent Danish cohort study 
showed that convictions were significantly increased 
among men with 47,XYY syndrome compared to con-
trols in all crime types, except for drug-related crimes 
and traffic offenses. Importantly, when adjusting for 
social economic status (SES), the total conviction rates 
were similar to controls, which means that the increased 
risk of convictions may be partly or fully explained by 
poor SES [33].
High levels of childhood inattention and impulsiv-
ity increase the likelihood that parents will respond 
with harsh discipline, inappropriate withdrawal from 
the child, or inconsistent parenting [34, 35], a finding 
that also applies in our case. The combination of vari-
ous interventions adapted to the specific patient’s devel-
opmental level i.e. milieu-therapy, during his inpatient 
stay, positive reinforcement and rewarding techniques, 
drug administration, psycho-education and support of 
the patient and his family all may have contributed to his 
improvement; special attention was given to the patient-
parent interaction as his disturbed behavior, aggressive-
ness and impulsiveness had led the parents to respond 
as described above. Nevertheless, it is not easy to deter-
mine which treatment element was most effective. Low 
self-esteem, impulsivity and emotional immaturity due 
to 47,XYY syndrome often leads to self-harming and 
suicidal behaviors while conduct disorder is associated 
with major depression [36]. Learning difficulties due 
to ADHD and 47,XYY syndrome lead children to be at 
increased risk for social isolation and school dropout. 
These findings, in combination with rigid thinking and 
impulsiveness [37], underline the need for early psycho-
social-educational intervention and parental training [8].
Genetic diagnostic testing can be very informative 
in the diagnostic process and should be applied also to 
patients in Psychiatry in case of complex clinical presen-
tation when multiple organ systems are affected. Multi-
system anomalies are indicative of potentially identifiably 
genetic aberrations. Many of the currently known micro-
deletion and microduplication syndromes have been 
associated to somatic symptoms and dysmorphological 
features such as is the case for 22q11.2 microdeletion 
syndrome [38, 39]. These dysmorphisms have found to be 
enriched in the psychiatric patient population [40]. In the 
case presented in this paper, iris coloboma was the symp-
tom that led us to perform genetic testing with aCGH. 
Known pathogenic microdeletions and duplications have 
highly variable phenotypes ranging from only minor dys-
morphisms to the face or hands to obesity, speech diffi-
culties, macrocephaly, and intellectual disability [41].
In the case presented here, the history of abuse by the 
parents, the disrupted family relations, the bullying by 
his peers, the educational difficulties, and the poor SES 
could be identified as additional risk factors relating to 
bad prognosis. As good prognostic factors we can iden-
tify the ending of the abuse after intervention, the child’s 
encouragement and support from parents and teach-
ers and the improvement of parental relations as results 
of parent training and family support by mental health 
professionals. Taken together, it appears that also in case 
of psychiatric patients presenting with complex genetic 
aberrations and additional psychosocial problems, tradi-
tional psychiatric and psychological approaches can lead 
to decrease of symptoms and improved functioning.
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